secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nutex Health Inc. (NUTX)
CIK:        0001479681
Form:       8-K
Filed at:   2022-04-04T23:59:59+00:00
Accession:  0001607062-22-000244
Event type: m_and_a
Sentiment:  neutral
Materiality: 1.00
Item codes: 2.01, 3.02, 3.03, 5.01, 5.02, 5.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nutex Health completes reverse merger with Clinigence; issues 592.8M shares, new board and name
--------------------------------------------------------------------------------

- Former Nutex equityholders received 592,791,712 shares (92.09% of post-merger total).
- Pre-merger shares outstanding: 48,444,979; post-merger: 643,736,691.
- Company renamed Nutex Health Inc.; ticker remains NUTX.
- New board includes Thomas Vo (CEO), Warren Hosseinion (President), and others.
- Lock-up on shares: one-third released at each 6/12/18 months post-closing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1479681/000160706222000244/0001607062-22-000244-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1479681/000160706222000244/clnh040422form8k.htm
  HTML page:      https://secwatch.observer/filing/0001607062-22-000244

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer